Cited 0 time in
- Title
- 형광특성이 향상된 풀러렌-실리카 나노입자, 이의 제조방법 및 이의 용도
- Alternative Title
- Fullererene-silica nanoparticles having improved luminescence, preparation method thereof and use thereof
- Inventor(s)
- 정진영; 정봉현
- Assignee(s)
- 한국생명공학연구원
- Application No.
- 12/993,908 (2011.01.07)
- Registration No.
- 8,715,738 (2014.05.06)
- Country
- 미국
- Abstract
- The present invention relates to fullerene-silica nanoparticles with improved fluorescence, a preparation method of the fullerene-silica nanoparticles, and use thereof. More specifically, the present invention relates to fullerene-silica nanoparticles with improved fluorescence in which fullerene and silica are covalently linked, a preparation method of the fullerene-silica nanoparticles, and use thereof. The preparation method of the fullerene-silica nanoparticles comprises the steps of: adding a surfactant to a non-polar organic solvent and a polar solvent and stirring them to form reverse micelles (step 1); adding fullerene to the reverse micelles formed in the step 1 and stirring them (step 2); and adding a silica precursor and a catalyst to a reaction solution containing the fullerene prepared in the step 2 and stirring them to prepare fullerene-silica nanoparticles (step 3). According to the present invention, fullerene-silica nanoparticles in the form of a uniform spherical shape of tens of nanometers can be prepared. As such prepared fullerene-silica nanoparticles have a large surface area due to a nanometer-sized structure, they have good reactivity. Compared with heavy metals or metal nanoparticles, the fullerene-silica nanoparticles, because of using silica, are harmless to a living body. Further, as the fullerene-silica nanoparticles exhibit strong fluorescence, they can be used as a contrast agent for in-vivo imaging or as a drug delivery carrier.
- Type
- Patent
- Appears in Collections:
- Division of Research on National Challenges > Environmental diseases research center > 2. Patents
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.